Skip to main content
. 2015 Feb 26;19(1):90. doi: 10.1186/s13054-015-0793-0

Figure 1.

Figure 1

Potential confounding factors not appropriately considered in the design or analysis of the clinical trials evaluating IVIG for the treatment of sepsis. Main factors are in bold. Other factors related to them are in standard type. IVIG, intravenous immunoglobulin; NK, natural killer.